Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 10918608 Use of cannabidiol in the treatment of epilepsy
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
October 13, 2015
0
Date of Patent
February 16, 2021
0
Patent Application Number
14881954
0
Patent Citations
US Patent 10111840 Use of cannabinoids in the treatment of epilepsy
US Patent 10137095 Use of cannabinoids in the treatment of epilepsy
0
US Patent 10092525 Use of cannabinoids in the treatment of epilepsy
Patent Citations Received
US Patent 11684598 Use of cannabinoids in the treatment of epilepsy
0
US Patent 11701330 Use of cannabinoids in the treatment of epilepsy
0
US Patent 11766411 Use of cannabinoids in the treatment of epilepsy
US Patent 12023346 Compositions and methods for treating epilepsy
0
US Patent 12121617 Transdermal delivery of cannabidiol
0
US Patent 11357741 Use of cannabinoids in the treatment of epilepsy
US Patent 11400055 Use of cannabidiol in the treatment of epilepsy
US Patent 11406623 Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
US Patent 11446258 Use of cannabinoids in the treatment of epilepsy
US Patent 11865102 Cannabidiol preparations and its uses
0
•••
Patent Inventor Names
Elizabeth Thiele
0
Geoffrey Guy
0
Stephen Wright
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
10918608
0
Patent Primary Examiner
Craig D Ricci
0
Find more entities like US Patent 10918608 Use of cannabidiol in the treatment of epilepsy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE